Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Keap1-Nrf2-ARE pathway is a central redox-sensitive cell signaling axis that monitors and manages cellular response to oxidative and electrophilic stress. Under basal conditions, Keap1 binds Nrf2 in the cytoplasm, promoting its ubiquitination and degradation via the proteasome. Upon exposure to oxidative or electrophilic agents, cysteine residues in Keap1 become modified, leading to release and stabilization of Nrf2. Stabilized Nrf2 translocates to the nucleus, dimerizes with small Maf proteins, and binds to antioxidant response elements (ARE) in the promoter regions of target genes, driving the expression of cytoprotective and detoxification enzymes. This pathway is vital for cell survival and homeostatic maintenance, but can also confer a growth advantage to malignant cells and enhance chemoresistance when aberrantly activated.
Covalent modification or alkylation of Keap1 cysteine residues, leading to release/activation of Nrf2. Inhibition of Nrf2 degradation through Keap1/CUL3 ubiquitin ligase complex inhibition. Stabilization/activation of Nrf2, allowing nuclear translocation and ARE-driven gene transcription.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kelch-like ECH-associated protein 1–nuclear factor erythroid 2-related factor 2–antioxidant response element signaling pathway (Keap1–Nrf2–ARE pathway).